Hepatitis C Virus Genotype 1-6 Protease Inhibitor Escape Variants: In Vitro Selection, Fitness and Resistance Patterns in the Context of the Infectious Viral Life Cycle

Antimicrobial agents and chemotherapy, 2016.

Cited by: 9|Bibtex|Views1|Links
WOS

Abstract:

Hepatitis C virus (HCV) NS3 protease inhibitors (PIs) are important components of novel HCV therapy regimens. Studies of PI resistance initially focused on genotype 1. Therefore, knowledge on determinants of PI resistance for the highly prevalent genotypes 2-6 remains limited. Using Huh7.5 cell-culture infectious HCV recombinants with gen...More

Code:

Data:

Your rating :
0

 

Tags
Comments